---
name: adaptivetrialdesign
title: Adaptive Trial Design Methods
menuGroup: meddecideExtraT
menuSubgroup: Advanced Bayesian Methods
menuSubtitle: Bayesian interim analysis and adaptive sample size re-estimation
version: '0.0.31'
jas: '1.2'

description:
    main: |
        Advanced adaptive trial design methods for clinical research including
        Bayesian interim analysis, adaptive sample size re-estimation, futility
        stopping rules, and group sequential designs. Designed for efficient
        clinical trial conduct with ethical early stopping capabilities.
    R:
        dontrun: false
        usage: |
            # Adaptive trial design with interim analysis
            adaptivetrialdesign(
                data = trial_data,
                outcome = "response",
                treatment = "arm",
                adaptation_type = "sample_size",
                interim_analysis = TRUE,
                futility_boundary = 0.1
            )

options:
    - name: data
      type: Data
      description:
          R: >
            The data as a data frame for adaptive trial design analysis.

    # Core trial variables
    - name: outcome
      title: Primary Outcome Variable
      type: Variable
      suggested: [continuous, nominal]
      permitted: [numeric, factor]

    - name: treatment
      title: Treatment Assignment Variable
      type: Variable
      suggested: [nominal, ordinal]
      permitted: [factor]

    - name: outcomeLevel
      title: Success/Response Level
      type: Level
      variable: (outcome)

    - name: stratification_variables
      title: Stratification Variables
      type: Variables
      suggested: [nominal, ordinal, continuous]
      permitted: [factor, numeric]
      default: null

    - name: time_variable
      title: Time to Event Variable
      type: Variable
      suggested: [continuous]
      permitted: [numeric]
      default: null
      description: "For time-to-event endpoints"

    # Adaptive design specification
    - name: adaptation_type
      title: Type of Adaptation
      type: List
      options:
        - title: "Sample Size Re-estimation"
          name: sample_size
        - title: "Treatment Arm Selection"
          name: arm_selection
        - title: "Dose Finding"
          name: dose_finding
        - title: "Futility Stopping"
          name: futility
        - title: "Efficacy Stopping"
          name: efficacy
        - title: "Seamless Phase II/III"
          name: seamless
        - title: "Group Sequential"
          name: group_sequential
      default: sample_size

    - name: design_framework
      title: Statistical Framework
      type: List
      options:
        - title: "Bayesian Adaptive"
          name: bayesian
        - title: "Frequentist Group Sequential"
          name: frequentist
        - title: "Hybrid Bayesian-Frequentist"
          name: hybrid
        - title: "Decision Theoretic"
          name: decision_theory
      default: bayesian

    # Interim analysis settings
    - name: interim_analysis
      title: Perform Interim Analysis
      type: Bool
      default: true

    - name: interim_timing
      title: Interim Analysis Timing
      type: List
      options:
        - title: "Information-Based"
          name: information
        - title: "Calendar Time-Based"
          name: calendar
        - title: "Patient Number-Based"
          name: patient_number
        - title: "Event-Based"
          name: event_based
      default: information

    - name: interim_fractions
      title: Interim Analysis Fractions
      type: String
      default: "0.25,0.50,0.75"
      description: "Comma-separated fractions of planned information/sample size"

    - name: max_interim_analyses
      title: Maximum Interim Analyses
      type: Integer
      default: 3
      min: 1
      max: 10

    # Stopping boundaries
    - name: efficacy_boundary
      title: Efficacy Stopping Boundary
      type: Number
      default: 0.95
      min: 0.50
      max: 0.99
      description: "Posterior probability threshold for efficacy stopping"

    - name: futility_boundary
      title: Futility Stopping Boundary
      type: Number
      default: 0.10
      min: 0.01
      max: 0.50
      description: "Posterior probability threshold for futility stopping"

    - name: boundary_type
      title: Boundary Construction Method
      type: List
      options:
        - title: "O'Brien-Fleming"
          name: obrien_fleming
        - title: "Pocock"
          name: pocock
        - title: "Lan-DeMets (O'Brien-Fleming)"
          name: lan_demets_obf
        - title: "Lan-DeMets (Pocock)"
          name: lan_demets_pocock
        - title: "Custom Alpha Spending"
          name: custom_spending
      default: obrien_fleming

    # Sample size and power
    - name: planned_sample_size
      title: Initially Planned Sample Size
      type: Integer
      default: 100
      min: 20
      max: 10000

    - name: minimum_effect_size
      title: Minimum Clinically Important Effect
      type: Number
      default: 0.5
      min: 0.01
      max: 10.0
      description: "Standardized or raw effect size"

    - name: target_power
      title: Target Statistical Power
      type: Number
      default: 0.80
      min: 0.50
      max: 0.99

    - name: type1_error_rate
      title: Type I Error Rate (Î±)
      type: Number
      default: 0.05
      min: 0.01
      max: 0.20

    - name: max_sample_size_inflation
      title: Maximum Sample Size Inflation
      type: Number
      default: 2.0
      min: 1.0
      max: 5.0
      description: "Maximum fold increase from planned sample size"

    # Bayesian prior specification
    - name: prior_type
      title: Prior Specification
      type: List
      options:
        - title: "Non-informative (Uniform)"
          name: noninformative
        - title: "Weakly Informative"
          name: weakly_informative
        - title: "Informative (Historical)"
          name: informative
        - title: "Skeptical Prior"
          name: skeptical
        - title: "Optimistic Prior"
          name: optimistic
      default: weakly_informative

    - name: historical_data_weight
      title: Historical Data Weight
      type: Number
      default: 0.1
      min: 0.0
      max: 1.0
      description: "Weight given to historical data in informative priors"

    - name: prior_parameters
      title: Custom Prior Parameters
      type: String
      default: ""
      description: "Comma-separated prior parameters (mean,sd for normal)"

    # Decision criteria
    - name: decision_criterion
      title: Decision Making Criterion
      type: List
      options:
        - title: "Posterior Probability"
          name: posterior_probability
        - title: "Bayes Factor"
          name: bayes_factor
        - title: "Predictive Probability"
          name: predictive_probability
        - title: "Expected Utility"
          name: expected_utility
        - title: "Value of Information"
          name: value_of_information
      default: posterior_probability

    - name: bayes_factor_threshold
      title: Bayes Factor Threshold
      type: Number
      default: 3.0
      min: 1.0
      max: 100.0

    - name: predictive_power_threshold
      title: Predictive Power Threshold
      type: Number
      default: 0.80
      min: 0.50
      max: 0.99

    # Simulation settings
    - name: run_simulations
      title: Run Operating Characteristics Simulation
      type: Bool
      default: true

    - name: n_simulations
      title: Number of Simulations
      type: Integer
      default: 1000
      min: 100
      max: 10000

    - name: true_effect_scenarios
      title: True Effect Size Scenarios
      type: String
      default: "0,0.3,0.5,0.8"
      description: "Comma-separated effect sizes for simulation"

    # MCMC settings (for Bayesian analyses)
    - name: mcmc_samples
      title: MCMC Samples per Analysis
      type: Integer
      default: 5000
      min: 1000
      max: 20000

    - name: mcmc_burnin
      title: MCMC Burn-in
      type: Integer
      default: 2000
      min: 500
      max: 10000

    - name: mcmc_chains
      title: Number of MCMC Chains
      type: Integer
      default: 3
      min: 1
      max: 6

    # Output and reporting options
    - name: show_design_summary
      title: Show Design Summary
      type: Bool
      default: true

    - name: show_interim_results
      title: Show Interim Analysis Results
      type: Bool
      default: true

    - name: show_stopping_boundaries
      title: Show Stopping Boundaries
      type: Bool
      default: true

    - name: show_sample_size_evolution
      title: Show Sample Size Evolution
      type: Bool
      default: true

    - name: show_operating_characteristics
      title: Show Operating Characteristics
      type: Bool
      default: true

    - name: show_posterior_evolution
      title: Show Posterior Evolution
      type: Bool
      default: true

    - name: show_decision_analysis
      title: Show Decision Analysis
      type: Bool
      default: true

    - name: show_interpretation
      title: Show Clinical Interpretation
      type: Bool
      default: true

    # Advanced options
    - name: alpha_spending_function
      title: Alpha Spending Function
      type: List
      options:
        - title: "O'Brien-Fleming Type"
          name: obf_type
        - title: "Pocock Type"
          name: pocock_type
        - title: "Power Family"
          name: power_family
        - title: "Custom Function"
          name: custom
      default: obf_type

    - name: spending_parameter
      title: Spending Function Parameter
      type: Number
      default: 1.0
      min: 0.1
      max: 10.0

    - name: blinded_sample_size_reestimation
      title: Blinded Sample Size Re-estimation
      type: Bool
      default: false

    - name: conditional_power_threshold
      title: Conditional Power Threshold
      type: Number
      default: 0.20
      min: 0.05
      max: 0.50

    # Clinical context
    - name: clinical_context
      title: Clinical Trial Context
      type: List
      options:
        - title: "Phase II Efficacy"
          name: phase2_efficacy
        - title: "Phase III Confirmatory"
          name: phase3_confirmatory
        - title: "Oncology Trial"
          name: oncology
        - title: "Cardiovascular Trial"
          name: cardiovascular
        - title: "Rare Disease Trial"
          name: rare_disease
        - title: "Pediatric Trial"
          name: pediatric
        - title: "General Clinical Trial"
          name: general
      default: general

    # Reproducibility
    - name: set_seed
      title: Set Random Seed
      type: Bool
      default: true

    - name: seed_value
      title: Random Seed Value
      type: Integer
      default: 42
      min: 1
      max: 999999

    # Regulatory considerations
    - name: regulatory_framework
      title: Regulatory Framework
      type: List
      options:
        - title: "FDA Guidance"
          name: fda
        - title: "EMA Guideline"
          name: ema
        - title: "ICH E9(R1)"
          name: ich_e9
        - title: "General Guidelines"
          name: general
      default: general

    - name: dmb_recommendations
      title: Include DMB Recommendation Templates
      type: Bool
      default: true
      description: "Generate templates for Data Monitoring Board recommendations"